To develop the next-generation metal agents for efficiently inhibiting tumor growth, a series of novel mononuclear, binuclear and trinuclear copper (Cu) thiophene-2-formaldehyde thiosemicarbazone complexes and a tetranuclear Cu 1,2,4-triazole-derived complex have been synthesized and their structure-activity relationships have been studied. The trinucleated Cu complex showed the strongest inhibitory
为了开发有效抑制肿瘤生长的下一代
金属制剂,一系列新型单核、双核和三核
铜(Cu)
噻吩-2-甲醛缩
氨基
硫脲配合物和四核Cu
1,2,4-三唑衍生配合物已被开发出来。并对其构效关系进行了研究。在所有Cu配合物中,三核Cu配合物对T24细胞表现出最强的抑制活性。其体内抗肿瘤作用优于
顺铂,且副作用减少。进一步的抗肿瘤机制研究表明,Cu配合物不仅诱导癌细胞凋亡,还通过抑制血管内皮细胞的迁移和侵袭、阻断细胞周期于G1期、诱导自噬来抑制肿瘤血管生成。